Shopping Cart 0
Cart Subtotal
USD 0

Luminex Corp (LMNX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9

Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Luminex Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Luminex Extends Distribution Agreement With EMD Millipore 11

Equity Offering 12

Nanosphere Raises USD10 Million in Public Offering of Shares 12

Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13

Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14

Acquisition 15

Luminex Acquires Nanosphere in Tender Offer 15

Luminex Corp-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 23

Financial Announcements 23

May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 23

Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 24

Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 25

Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 26

Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 27

May 02, 2016: Luminex Reports First Quarter 2016 Results 28

Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Luminex Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9

Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Luminex Extends Distribution Agreement With EMD Millipore 11

Nanosphere Raises USD10 Million in Public Offering of Shares 12

Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13

Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14

Luminex Acquires Nanosphere in Tender Offer 15

Luminex Corp, Key Competitors 18

Luminex Corp, Key Employees 19

Luminex Corp, Other Locations 21

Luminex Corp, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Luminex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9

Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Luminex Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Luminex Extends Distribution Agreement With EMD Millipore 11

Equity Offering 12

Nanosphere Raises USD10 Million in Public Offering of Shares 12

Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13

Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14

Acquisition 15

Luminex Acquires Nanosphere in Tender Offer 15

Luminex Corp-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 23

Financial Announcements 23

May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 23

Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 24

Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 25

Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 26

Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 27

May 02, 2016: Luminex Reports First Quarter 2016 Results 28

Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Luminex Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Luminex Corp, Deals By Therapy Area, 2011 to YTD 2017 8

Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9

Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Luminex Extends Distribution Agreement With EMD Millipore 11

Nanosphere Raises USD10 Million in Public Offering of Shares 12

Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13

Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14

Luminex Acquires Nanosphere in Tender Offer 15

Luminex Corp, Key Competitors 18

Luminex Corp, Key Employees 19

Luminex Corp, Other Locations 21

Luminex Corp, Subsidiaries 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Luminex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.